IC
PRAX icon

Inscription Capital’s Praxis Precision Medicines PRAX Stock Holding History

Inscription Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Hold
866
– – 0.03% 555
2026
Q1 		$279K Hold
866
– – 0.03% 510
2025
Q4 		$255K Buy
+866
New +$161K 0.03% 536

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Inscription Capital's PRAX Position: Q2 2026 in Review

Inscription Capital held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 866 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #555.

Inscription Capital first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Inscription Capital held 866 shares of Praxis Precision Medicines worth $290K as of Q2 2026.
  • Inscription Capital left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 0.03% of Inscription Capital's portfolio in Q2 2026, its #555 holding.
  • Inscription Capital first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.